vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and CSP INC (CSPI). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $12.0M, roughly 1.8× CSP INC). CSP INC runs the higher net margin — 0.8% vs -373.3%, a 374.1% gap on every dollar of revenue. CSP INC produced more free cash flow last quarter ($-3.0M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
CSP Inc. is a U.S.-based technology firm offering cybersecurity solutions, managed IT services, high-performance computing systems, and IT consulting support. It serves enterprises across healthcare, finance, manufacturing, and public sectors in North America and select global markets.
AUTL vs CSPI — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $12.0M |
| Net Profit | $-79.1M | $91.0K |
| Gross Margin | — | 39.3% |
| Operating Margin | -337.9% | -0.9% |
| Net Margin | -373.3% | 0.8% |
| Revenue YoY | — | -23.2% |
| Net Profit YoY | 3.6% | -80.7% |
| EPS (diluted) | $-0.30 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $12.0M | ||
| Q3 25 | $21.2M | $14.5M | ||
| Q2 25 | $20.9M | $15.4M | ||
| Q1 25 | $9.0M | $13.1M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | $0 | $13.0M | ||
| Q2 24 | $0 | $13.1M | ||
| Q1 24 | $10.1M | $13.7M |
| Q4 25 | — | $91.0K | ||
| Q3 25 | $-79.1M | $-191.0K | ||
| Q2 25 | $-47.9M | $-264.0K | ||
| Q1 25 | $-70.2M | $-108.0K | ||
| Q4 24 | — | $472.0K | ||
| Q3 24 | $-82.1M | $-1.7M | ||
| Q2 24 | $-58.3M | $-185.0K | ||
| Q1 24 | $-52.7M | $1.6M |
| Q4 25 | — | 39.3% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 28.8% | ||
| Q1 25 | — | 32.0% | ||
| Q4 24 | — | 29.1% | ||
| Q3 24 | — | 28.4% | ||
| Q2 24 | — | 35.0% | ||
| Q1 24 | — | 47.3% |
| Q4 25 | — | -0.9% | ||
| Q3 25 | -337.9% | -3.7% | ||
| Q2 25 | -292.6% | -7.9% | ||
| Q1 25 | -726.3% | -7.6% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | — | -15.7% | ||
| Q2 24 | — | -5.5% | ||
| Q1 24 | -384.1% | 9.0% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | -373.3% | -1.3% | ||
| Q2 25 | -229.0% | -1.7% | ||
| Q1 25 | -781.1% | -0.8% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | -12.7% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | -522.1% | 11.6% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.30 | $-0.02 | ||
| Q2 25 | $-0.18 | $-0.03 | ||
| Q1 25 | $-0.26 | $-0.01 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-0.31 | $-0.17 | ||
| Q2 24 | $-0.22 | $-0.02 | ||
| Q1 24 | $-0.24 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $24.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $44.8M |
| Total Assets | $661.9M | $69.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $24.9M | ||
| Q3 25 | $86.1M | $27.4M | ||
| Q2 25 | $123.8M | $26.3M | ||
| Q1 25 | $95.8M | $29.5M | ||
| Q4 24 | — | $30.7M | ||
| Q3 24 | $657.1M | $30.6M | ||
| Q2 24 | $705.9M | $28.9M | ||
| Q1 24 | $758.5M | $27.1M |
| Q4 25 | — | $44.8M | ||
| Q3 25 | $265.5M | $44.6M | ||
| Q2 25 | $346.5M | $47.5M | ||
| Q1 25 | $371.1M | $47.5M | ||
| Q4 24 | — | $47.5M | ||
| Q3 24 | $477.0M | $47.3M | ||
| Q2 24 | $527.8M | $48.1M | ||
| Q1 24 | $582.0M | $48.2M |
| Q4 25 | — | $69.2M | ||
| Q3 25 | $661.9M | $71.2M | ||
| Q2 25 | $721.0M | $66.8M | ||
| Q1 25 | $746.3M | $67.1M | ||
| Q4 24 | — | $67.5M | ||
| Q3 24 | $827.5M | $69.4M | ||
| Q2 24 | $853.6M | $66.8M | ||
| Q1 24 | $901.4M | $64.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-2.9M |
| Free Cash FlowOCF − Capex | $-72.3M | $-3.0M |
| FCF MarginFCF / Revenue | -341.2% | -25.1% |
| Capex IntensityCapex / Revenue | 20.8% | 0.9% |
| Cash ConversionOCF / Net Profit | — | -32.04× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | $-2.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.9M | ||
| Q3 25 | $-67.9M | $1.9M | ||
| Q2 25 | $-72.8M | $-3.3M | ||
| Q1 25 | $-75.6M | $1.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $-76.7M | $-1.5M | ||
| Q2 24 | $-51.1M | $2.4M | ||
| Q1 24 | $-40.5M | $1.7M |
| Q4 25 | — | $-3.0M | ||
| Q3 25 | $-72.3M | $1.7M | ||
| Q2 25 | $-80.1M | $-3.3M | ||
| Q1 25 | $-83.8M | $1.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $-86.3M | $-1.5M | ||
| Q2 24 | $-51.9M | $2.4M | ||
| Q1 24 | $-41.0M | $1.6M |
| Q4 25 | — | -25.1% | ||
| Q3 25 | -341.2% | 11.5% | ||
| Q2 25 | -382.6% | -21.7% | ||
| Q1 25 | -933.1% | 14.5% | ||
| Q4 24 | — | 10.8% | ||
| Q3 24 | — | -11.7% | ||
| Q2 24 | — | 17.9% | ||
| Q1 24 | -406.8% | 11.9% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 20.8% | 1.6% | ||
| Q2 25 | 34.8% | 0.4% | ||
| Q1 25 | 91.8% | 0.1% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | 5.3% | 0.1% |
| Q4 25 | — | -32.04× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.69× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AUTL
Segment breakdown not available.
CSPI
| Products | $6.7M | 56% |
| Services | $5.3M | 44% |
